Treatment of cardiac manifestations in Fabry disease with the oral drug Migalastat: First 12 months results from a cohort of amenable all-comers

26 August 2018 (17:15 - 17:25)
Organised by:
Congress Presentation Part of: Cardiomyopathy in Fabry disease Infiltrative Myocardial Disease ESC Premium Access ESC Congress 2018

ESC 365 is supported by

ESC 365 is supported by